おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cygnus Biosciences
company
About
Cygnus Biosciences is a Chinese gene sequencing company.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $19.60M
- Industries
- Biotechnology,Clinical Trials,Health Diagnostics,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Cygnus Biosciences (Beijing) Co., Ltd. is a high-tech company specializing in R & D and industrialization of gene sequencing platform and committed to clinical medicine screening and diagnosis.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$19.60M
Cygnus Biosciences has raised a total of
$19.60M
in funding over 2 rounds. Their latest funding was raised on
Nov 14, 2017 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 14, 2017 | Series B | $19.60M | 2 | — | — | Detail |
| Aug 28, 2015 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Cygnus Biosciences is funded by 2 investors.
Jinggong Hongyuan
and General Technology Venture Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
General Technology Venture Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
